EnBiotix
is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders... Read moreEnBiotix
is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders... Read more
News
Dec 31, 2021
Citybizlist
EnBiotix: EnBiotix Closes $11M Pre-Merger Financing
Dec 29, 2021
BioSpace
EnBiotix: Polyphor to Inform about the Financing of its Merger Partner EnBiotix
Dec 29, 2021
FE Investegate
EnBiotix: Polyphor AG : Merger partner EnBiotix
Dec 29, 2021
OINDPnews
EnBiotix: EnBiotix raises $11 million in financing round led by Vectura for further development of ColiFin, murepavidin
Dec 15, 2021
FinanzNachrichten
EnBiotix: Polyphor AG: Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin
Oct 29, 2021
FE Investegate
EnBiotix: Polyphor AG : Extraordinary General Meeting
Oct 15, 2021
centralcharts
Press Release: EnBiotix : EQS-Adhoc: Swiss Takeover Board confirms Absence of an Obligation to make a Public Takeover Offer in connection with planned Enbiotix Merger
Sep 27, 2021
StreetInsider
Press Release: EnBiotix : Polyphor Publishes Invitation to Extraordinary General Meeting and Announces Financial Results for the First Half 2021
Sep 10, 2021
MarketScreener
EnBiotix: Polyphor and EnBiotix announce closing of purchase agreement of Inhaled Murepavadin by EnBiotix
Sep 09, 2021
Global Legal Chronicle
EnBiotix: Polyphor's Merger Agreement With EnBiotix
EnBiotix Competitors
1
2
3
4
5
6
7
8
9
10